China stocks climb to three-month high on for outlook for policy support, easier regulations on private companies
- Utilities and raw-material producers led onshore stock winners as China pledges to stabilise growth in 2022, front-load policy support
- Excessive capital growth may instead be curbed with other forms of mechanism, economic work conference concluded
The Shanghai Composite Index gained 0.4 per cent to 3,681.08 at the close of Monday trading, the highest level since September 13. The CSI 300 Index of biggest companies in Shanghai and Shenzhen added 0.6 per cent. Utilities and raw-material producers led winners.
The Hang Seng Index slipped 0.2 per cent in Hong Kong, reversing an intra-day gain of as much as 1.6 per cent. Sunny Optical was the worst performer on the benchmark with a 3.2 per cent decline. Alibaba Group Holding ended with a 0.1 per cent loss, surrendering a 4.6 per cent rally.
“Sentiment is gradually turning towards Chinese stocks, with foreign flows being positive, said Thomas Poullaouec, head of Asia-Pacific multi-asset solutions at T. Rowe Price, said in a note to clients. “Inflationary pressures are far more subdued than in the Western world; this gives room for the policymakers to ease from here.”
Policy easing bets helped lift the Hang Seng Index from a 14-month low last week, adding back US$260 billion of market value.
Elsewhere, Yonghe Medical Group, which provides hair-related health care services, climbed 5.1 per cent from the initial public offering price to HK$16.60 on the first day of trading in Hong Kong.
Major Asian markets were mixed on Monday as investors keep their eye on a handful of central bank policy meetings this week. Stocks in Japan and Australia advanced 0.7 per cent and 0.4 per cent respectively, while those in South Korea dropped 0.3 per cent.